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The distal lung contains terminal bronchioles and alveoli that facilitate gas exchange. 
Three-dimensional in vitro human distal lung culture systems would strongly 
facilitate investigation of pathologies including interstitial lung disease, cancer, and 
SARS-CoV-2-associated COVID-19 pneumonia. We generated long-term feeder-free, 
chemically defined culture of distal lung progenitors as organoids derived from single 
adult human alveolar epithelial type II (AT2) or KRT5+ basal cells. AT2 organoids 
exhibited AT1 transdifferentiation potential while basal cell organoids developed 
lumens lined by differentiated club and ciliated cells. Single cell analysis of basal 
organoid KRT5+ cells revealed a distinct ITGA6+ITGB4+ mitotic population whose 
proliferation further segregated to a TNFRSF12Ahi subfraction comprising ~10% of 
KRT5+ basal cells, residing in clusters within terminal bronchioles and exhibiting 
enriched clonogenic organoid growth activity. Distal lung organoids were created 
with apical-out polarity to display ACE2 on the exposed external surface, facilitating 
SARS-CoV-2 infection of AT2 and basal cultures and identifying club cells as a novel 
target population. This long-term, feeder-free organoid culture of human distal lung, 
coupled with single cell analysis, identifies unsuspected basal cell functional 
heterogeneity and establishes a facile in vitro organoid model for human distal lung 
infections including COVID-19-associated pneumonia.
The distal lung performs essential respiratory functions which can 
be compromised by inflammatory, neoplastic or infectious disorders 
such as COVID-19 pneumonia, whose study would be facilitated by 
robust human in vitro models. The identities of human stem cells that 
regenerate distal lung epithelium in vivo over the lifespan are inferred 
from mouse despite differences between these species1. In humans, 
basal stem cells span the entire airway tree in contrast to mouse where 
club cells2 and/or Secretoglobin 1A1 (SCGB1A1)-expressing non-club 
cells3 renew the distal bronchioles during aging. In the gas exchange 
region, murine alveolar epithelial type II (AT2) cells generate AT1 
and AT2 cells during homeostasis4,5, and additional progenitors are 
recruited by severe injury3,6–9. The presence and/or roles of faculta-
tive progenitors in human lung is unknown. Human AT2 cells can 
be differentiated into AT1 cells but cultures are short-lived, neither 
demonstrating long-term self-renewal nor enabling expansion for 
disease modeling4,10,11, while requirements for feeder cells impede 
definition of specific niche components12,13. Here, we established 
long-term organoid culture of distal human lung, including AT2 and 
basal stem cells, which was applied to functional progenitor valida-
tion and SARS-CoV-2 modeling.
Clonogenic alveolar and basal organoids
We empirically defined media conditions supporting clonal expan-
sion of distal human lung progenitors in collagen/laminin extracel-
lular matrix from 136 individuals (Fig. 1a, Supplementary Table 1). 
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Together, EGF and the BMP antagonist NOGGIN supported growth 
of disaggregated distal lung cells or purified epithelial fractions 
thereof (Extended Data Fig. 1a-c). Single cells (Extended Data Fig. 1d-g) 
expanded into either SFTPC+HTII-280+ AT2 cystic organoids (Fig. 1b–e) 
or KRT5+ solid organoids expressing the basal cell marker KRT5 
(Fig. 1b, f–h).
Single cell RNA-sequencing (scRNA-seq) of distal lung organoids 
confirmed SFTPC+ AT2, KRT5+ basal and SCGB1A1+ club cell popula-
tions (Fig. 1i–j, Extended Data Fig. 2). Cells co-expressing KRT5 and 
SCGB1A1 bridged basal and club populations, suggesting a transi-
tional state (Fig. 1j-k, Extended Data Fig. 2) supported by SPADE14 and 
Monocle15 trajectory analysis (Extended Data Fig. 3, Supplementary 
Table 2).
Human AT2 organoid characterization
We generated pure AT2 organoids from mixed cultures via lamellar 
body uptake of lysosomal dyes (Extended Data Fig. 4a-b, Supplemen-
tary Figure 1). EPCAM+LysoTracker+ AT2 cells clonally expanded up 
to 180 days (Fig. 1l-m, Extended Data Fig. 4c-d). Chemically defined 
EGF/NOGGIN medium was sufficient for baseline clonal AT2 organoid 
proliferation that was attenuated by blocking endogenous WNT bio-
synthesis (Extended Data Fig. 4e), recapitulating essential autocrine 
WNT signaling in mouse AT2 cells16. Growth was enhanced by adding 
fibroblast conditioned medium containing serum and Wnt agonists 
(Extended Data Fig. 4f). Transmission electron microscopy revealed 
microvilli and lamellar bodies characteristic of mature AT2 cells (Fig. 1n, 
Extended Data Fig. 4g). AT2 organoids upregulated AT1 markers when 
cultured on glass with serum (Fig. 1o-p).
Single cell RNA-seq of mixed distal lung organoids or purified 
alveolar organoids revealed uniformly high-level expression of 
canonical AT2 cell markers in alveolar populations (Fig. 1i-k, Fig. 1q, 
Extended Data Fig. 2, Supplementary Data 1). AT2 cell subsets were 
not readily observed, and cell cycle mRNAs did not localize to a 
specific AT2 subpopulation (Fig. 1q, Supplementary Data 1, Sup-
plementary Table 3).
Differentiation of human basal organoids
Basal cell organoids in mixed distal lung culture grew more rapidly 
than alveolar organoids and initially formed solid KRT5+ spheroids 
(Fig. 1a-b, f-h). However, by 1 month ~50% of organoids developed single 
or occasionally multiple lumens (Fig. 2a-b, Extended Data Fig. 5a-c) 
with emergence of club (SCGB1A1+KRT5–) and ciliated (AcTUB+KRT5–) 
cells lining the interior surface (Fig. 2a, b). Basal cultures purified by 
density sedimentation exhibited serial clonal outgrowth, EGF and NOG-
GIN dependence, and cavitation lined by luminal SCGB1A1+ club and 
AcTUB+ ciliated cells (Extended Data Fig. 5d–h, Fig. 2c-d, Supplementary 
Video 1-2). Similar differentiation occurred upon organoid transfer to 
2D air-liquid interface (ALI) culture (Fig. 2e).
Distinct subtypes of airway basal cells
scRNA-seq clustering of organoid KRT5+ basal cells from multiple indi-
viduals reproducibly identified two populations, Basal 1 and Basal 
2 (Fig. 2f–g, Extended Data Fig. 6a, Supplementary Data 1). Basal 1 
included an actively cycling subpopulation (Basal 1.2) enriched in 
proliferation markers (PCNA, CDK1) and GSEA cell cycle processes 
(Fig. 2f-g, Extended Data Fig. 6a-c, Supplementary Table 3). Basal 1 
but not Basal 2 expressed canonical lung basal cell mRNAs such as 
TP6317, integrin α6 (ITGA6) and integrin β4 (ITGB4) encoding a binding 
partner of ITGA618 and marking murine Lineage Negative Epithelial 
Progenitors (LNEPs)7 (Fig. 2h). Basal 2 was enriched in vesicular trans-
port, endoplasmic reticulum processes and squamous markers (Fig. 2g, 
Supplementary Table 3).
TNFRSF12A+ progenitor characterization
We examined the differentially expressed Basal 1 gene TNFRSF12A (Fn14, 
TWEAKR) encoding a membrane receptor (Fig. 2g–h, Supplementary 
Table 4) given potential utility for FACS isolation and homology to the 
intestinal stem cell marker TNFRSF1919. Unbiased pseudotime analysis 
revealed a continuous single-cell trajectory connecting KRT5+ Basal 1 to 
SCGB1A1+ club cells where TNFRSF12A mRNA was strongly associated 
with proliferation marker MKI67 (Fig 2i, Extended Data Fig. 3). When 
Basal 1 cells co-expressing EPCAM, ITGA6 and ITGB4 were divided into 
TNFRSF12A-low, -medium and -high mRNA-expressing fractions, a 
proliferative gene module20 was significantly enriched in the highest 
(TNFRSF12Ahi) versus lowest quartile (TNFRSF12Alo) (Extended Data 
Fig. 6d-f). To determine if this correlation reflected intrinsic prolifera-
tive potential, we fractionated total distal lung organoids by FACS into 
EPCAM+ITGA6+ITGB4+ Basal 1 cells and then TNFRSF12Ahi and TNFRS-
F12Aneg subsets (Fig. 2j), which upon culture revealed 4-12x greater 
clonogenic organoid-forming capacity of the former (Fig. 2k-l).
We examined lineage relationships between Basal 1 and Basal 
2 by fractionating density-sedimented KRT5+ basal organoids 
by FACS into EPCAM+ITGA6+ITGB4+TNFRSF12Ahi (Basal 1) and 
EPCAM+ITGA6-ITGB4-TNFRSF12Aneg (Basal 2) populations (Extended 
Data Fig. 7a). Clonogenic organoid formation was strongly enriched in 
Basal 1 versus Basal 2 from three separate individuals (Extended Data 
Fig. 7b-d). Basal 2-enriched genes SPRR1B and TMSB4X (Fig. 2g, Sup-
plementary Table 3) were transiently induced in Basal 1 cell organoids 
(Extended Data Fig. 7e-f), suggesting potential Basal 2 differentiation 
from Basal 1.
The NOTCH target gene HES1 was one of the most differentially 
expressed Basal 1 loci, where gene networks included NOTCH1, 
NOTCH2 and JAG1 (Fig. 2g, Supplementary Table 3). NOTCH inhi-
bition significantly increased basal organoid proliferation from 
TNFRSF12AhiEPCAM+ITGA6+ITGB4+ cells (Extended Data Fig. 7g-h), 
suggesting NOTCH restraint of growth. Conversely, NOTCH agonism 
did not affect proliferation but induced SCGB1A1, similar to upper 
airway cells21,22 (Extended Data Fig. 7i).
TNFRSF12A+ cell characterization in lung
Immunostaining of human distal lung revealed TNFRSF12A+ basal cells 
enriched intermittently at the tips or bases of bronchiolar furrows 
(Fig. 3a, Extended Data Fig. 8a-b), the latter recognized as a goblet 
cell niche23. TNFRSF12A was detected in diverse lung stromal and epi-
thelial cells yet clearly marked a minor population of KRT5+ and p63+ 
basal cells (Fig. 3a, Extended Data Fig. 8a-c). The TNFRSF12A+ subset 
of KRT5+ basal cells exhibited a higher mitotic index than total KRT5+ 
cells in vivo (Fig. 3b-c), consistent with organoid scRNA-seq (Fig. 2i). 
FACS analysis of human distal lung confirmed TNFRSF12A expression 
in 10.9% of basal cells (Extended Data Fig. 8d, top).
Upon prospective culture directly from human lung without an orga-
noid intermediate, FACS-isolated EPCAM+ITGA6+ITGB4+TNFRSF12Ahi 
cells (i.e., TNFRSF12Ahi Basal 1) (Extended Data Fig. 8d, bottom) 
exhibited 15-fold increased KRT5+ organoid formation versus 
EPCAM+ITGA6+ITGB4+TNFRSF12Aneg cells (i.e., TNFRSF12neg Basal 1) 
(Fig. 3d-e). TNFRSF12Ahi basal organoids also differentiated to SCGB1A1+ 
club and AcTUB+ ciliated cells in prolonged culture (Fig. 3f) or when 
transitioned to 2D ALI (Fig. 3g).
SARS-CoV-2 and H1N1 organoid infection
Influenza virus H1N1 avidly infected distal lung organoids, which also 
expressed influenza receptors (Extended Data Fig. 9a-d), similar to 
proximal airway organoids24,25. Organoid influenza H1N1 PR8 infection 
was inhibited by nucleoside analogs consistent with previous studies26 














classes in 48-well format revealed differential activity (Extended Data 
Fig. 9f), suggesting utility for scalable therapeutics discovery.
In COVID-19 pneumonia, severe distal lung SARS-CoV-2 infection 
induces alveolar damage and respiratory failure27. Organoid scRNA-seq 
at time points prior to ciliated differentiation revealed SARS-CoV-2 
receptor ACE2 and processing protease TMPRSS2 mRNAs predomi-
nantly in club and AT2 cells (Extended Data Fig. 10a), consistent with 
ACE2 expression in KRT5- differentiated interior luminal cells (Fig. 2a). 
To facilitate SARS-CoV-2 access to ACE2-expressing luminal cells we 
adapted an apical-out suspension culture polarization method28 to 
distal lung organoids (Extended Data Fig. 10b). Within 48h in suspen-
sion, organoids reorganized into apical-out epithelial spheroids with 
microvilli, apical junctions, and motile cilia facing the organoid exterior. 
Differentiation of outwardly oriented ciliated cells accelerated over 
5 days and progressed over weeks (Fig. 4a; Extended Data Fig. 10c-f; Sup-
plemental Video 3). Apical-out basal organoids also displayed increased 
outwardly facing club cells with apical secretory granules (Fig. 4a; 
Extended Data Fig. 10g) while apical-out AT2 organoids exhibited AT1 
differentiation (Extended Data Fig. 10h-j). Crucially, in apical-out orga-
noids, ACE2 localized to apical cell membranes on the external organoid 
surface (Fig. 4b, Extended Data Fig. 10k).
SARS-CoV-2 infected apical-out mixed distal lung organoids with 
induction of unspliced SARS-CoV-2 genomic RNA to levels approaching 
the abundantly expressed U3 snoRNA (Fig. 4c, left), replication-specific 
SARS-CoV-2 subgenomic RNA (sgRNA) (Fig. 4c, right) and infectious 
virion production with VeroE6 cell plaque formation (35 PFU/mL 
from organoid lysates and 65 PFU/mL from organoid supernatants). 
In SARS-CoV-2-infected basal organoids, double-stranded RNA (dsRNA) 
appeared by 48h (Fig. 4d) and SARS-CoV-2 nucleocapsid protein (NP) 
by 96h (Fig. 4e). Approximately 10% of AT2 organoids displayed promi-
nent SARS-CoV-2 NP expression in SFTPC+ cells; remaining organoids 
were devoid of infection (Fig. 4f). Similarly, SARS-CoV-2 infected ~10% 
of basal organoids. In 2,621 total distal airway basal cells represent-
ing cultures from 4 individuals (Supplementary Table 5), SARS-CoV-2 
infection was not detected in KRT5+ basal or AcTUB+ ciliated cells (odds 
ratio 0, p-value < 0.05), in contrast to SARS-CoV-2 infection of upper 
airway ciliated cells in 2D ALI culture29,30. However, SARS-CoV-2 NP and 
dsRNA immunofluorescence were primarily present in SCGB1A1+ club 
cells (Fig. 4g-h) which were strongly associated with and accounted 
for 79% of NP/dsRNA-positive cells (odds ratio 19.33, p < 0.0001); 
21% of infected cells lacked SCGB1A1 (Fig. 4g-h, Supplementary 
Table 5). Overall, these studies indicated direct SARS-CoV-2 infec-
tion of AT2 cells, and implicated club cells as a novel distal lung target 
population.
Discussion
Here, we applied long-term human distal lung organoid cultures to 
progenitor discovery and infectious disease modeling. Our find-
ings extend upon prior short-term and feeder-dependent adult lung 
culture methods4,10,11 and present an alternative to iPSC differentia-
tion techniques31–34. Organoids contained interrelated subtypes of 
KRT5+ human distal lung basal cells, Basal 1 and Basal 2. Notably, the 
TNFRSF12A-expressing Basal 1 subfraction possessed enriched clo-
nogenic progenitor activity, establishing functional precedent for 
a proliferation-enriched basal cell subtype. TNFRSF12A, while by no 
means exclusively present in basal cells, within the basal layer often 
localizes to a postulated niche in airway furrow bases and tips23, extend-
ing recent notions of lung epithelial spatial specialization35. Conceiv-
ably, TNFRSF12A or analogous markers could distinguish basal cell 
progenitor subsets in other tissues. The current organoids also ena-
ble facile exploration of SARS-CoV-2 distal lung infection, relevant to 
COVID-19-associated pneumonia27 and implicate SCGB1A1+ club cells 
as a novel target whose infection could compromise protective lung 
glycosaminoglycans and precipitate a vicious infection cycle. Ciliated 
cell infection was not observed, in contrast to 2D ALI lung studies29,30 
and could require alternative culture conditions. SCGB1A1-negative 
populations were also infected and are under further investigation; 
for example, bronchial transient secretory cells express ACE2 and 
TMPRSS236.
Overall, single cell analysis of organoid cultures, exemplified here, 
may represent a general strategy for identifying and functionally vali-
dating candidate stem cells in slowly proliferating tissues. The culture 
of progenitors for all adult distal lung epithelial lineages, including 
alveoli, should substantially enable disease modeling including neo-
plastic and interstitial lung conditions12 and allow tissue engineering 
and precision medicine applications. Finally, this organoid system 
should facilitate diverse investigations of pulmonary pathogens, 
including the SARS-CoV-2 distal lung infection associated with fulmi-
nant respiratory failure.
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Fig. 1 | Clonogenic expansion of human distal lung organoids. a. Human 
distal lung d14 (day 14) organoid cultures contain cystic and solid organoids, 
brightfield and H&E. Scale bar 100 µm. b, Whole-mount immunofluorescence 
(IF), anti-KRT5 (basal), -SFTPC (AT2) and -SCGB1A1 (club), scale bar 100 µm, d32. 
c-e, Alveolar organoids, d32. c, Cystic AT2 organoid, H&E, scale bar 25 µm. 
d, Whole-mount fluorescence for anti-SFTPC, anti-HTII-28, phalloidin and 
DAPI, scale bar 50 µm. e, Anti-Ki67 and DAPI of adjacent section of (d). f-h, Basal 
organoids, d32. f, H&E, scale bar 50 µm. g, Whole-mount IF, anti-KRT5 and DAPI, 
scale bar 100 µm. h, Anti-Ki67 and DAPI immunostaining of (g). i-k, scRNA-seq 
of d28 total distal lung organoids. i, t-SNE plot of 7,285 individual cells 
demonstrating AT2, basal, and club populations. j, Violin plot, SFTPC (AT2), 
KRT5 (basal), SCGB1A1 (club). k, Feature plots, tSNE. l, Brightfield microscopy, 
AT2 organoids d180, scale bar 200 µm. m, H&E from (l), d180, scale bar 50 µm. 
n, Transmission electron microscopy of d32 AT2 organoid, LB = lamellar body, 
scale bar 5 µm. o-p, AT2 organoid at d32 (o); culture on glass for 10 additional 
days induces AT1 differentiation (p). Anti-HTI-56 (AT1) and -HTII-280 (AT2)  
IF staining, scale bar 50 µm. q, scRNA-seq feature plots of 2,780 AT2 organoid 














Fig. 2 | Basal organoid differentiation and TNFRSF12Ahi progenitor 
discovery. a-b, Basal organoid differentiation in mixed culture. Lumens are 
lined by acetylated tubulin+ (AcTUB) ciliated (a) and SCGB1A1+ club cells (b) 
which express SARS-CoV-2 receptor ACE2 but lack KRT5, IF, d26, scale bar 20 
µm. c-e, Sedimented basal organoid culture. c, Club differentiation, d38, 
shown by whole-mount fluorescence for anti-SCGB1A1 (red), phalloidin (white), 
and DAPI (blue), scale bar 50 µm. d, Ciliated differentiation, confocal 
transmission image, scale bar 20 µm. e, AcTUB+ ciliated and SCGB1A1+ club cells 
upon organoid replating in 2D ALI, IF, scale bar 50 µm. f-g, scRNA-seq of KRT5+ 
basal cells from Fig. 1i. f, Basal 1 and Basal 2 subclusters. Basal 1 is subdivided 
into Basal 1.1 and 1.2, the latter expressing proliferative mRNAs CDK1 and PCNA, 
tSNE. g, Basal 1 and Basal 2 differential gene expression. h, Basal marker 
transcript t-SNE overlays of (f), log10 UMI. i, Relative gene expression kinetic 
plots of (f-g) across the pseudotime trajectory (n = 3,721 cells). j, FACS isolation 
of TNFRSF12Ahi versus TNFRSF12Aneg cells from mixed distal lung organoids, 
pre-gated on live singlets. k, d14 organoid culture of ( j), brightfield.  
l, Quantitation of (k), *** = p < 0.001 (p = 1.0 x 10-4) two-tailed Student’s t-test. 















Fig. 3 | Characterization of TNFRSF12Ahi Basal 1 cells from intact human 
lung. a, Left, anti-KRT5 (red) and anti-TNFRSF12A (green) IF of human distal 
lung, DAPI = blue, scale bar 100 µm. The left panel yellow boxed area is depicted 
with (middle) and without (right) DAPI, scale bar 100 µm. b, Distal airway 
TNFRSF12A+ basal cell proliferation, IF, KRT5 (red), TNFRSF12A (green), KI67 
(white), DAPI (blue). Scale bar 100 µm. c, Mitotic index of TNFRSF12A+ KRT5+ 
cells from (b), 3 independent experiments. K5+ = total KRT5+, K5+T+ = 
TNFRSF12A+ KRT5+, boxplots represent first quartile, median, third quartile, 
and whiskers represent minimum and maximum ** = p < 0.01 (4.4 x 10-3), two 
tailed student’s t-test. d, Anti-KRT5 IF of FACS-isolated TNFRSF12Aneg and 
TNFRSF12Ahi d14 organoid culture, scale bar 500 µm. e, Quantitation of (d); 
Data in d represent n = 5 independent experiments for each TNFRSF12A 
population. Boxplots represent first quartile, median, third quartile, and 
whiskers represent minimum and maximum, p = 1.1 x 10-3, two tailed  
student’s t-test. f, H&E and anti-KRT5, -TNFRSF12A, -SCGB1A1, and -AcTUB 
immunostaining of organoids from the TNFRSF12Ahi fraction of FACS-sorted 
EPCAM+ITGA6+ITGB4+ distal lung. Scale bar 50 µm. g, H&E and anti-SCGB1A1 or 
AcTUB IF of 2D ALI cultures from basal cell organoids from TNFRSF12Ahi basal 














Fig. 4 | SARS-CoV-2 infection of apical-out distal lung organoids.  
a, Polarization and surface localization of SCGB1A1+ club cells (green) and 
AcTUB+ ciliated cells (white) upon ECM non-polarized growth (left) or 
apical-out suspension culture (right), IF. b, Transverse section of apical-out 
basal organoid as in (a), stained with anti-ACE2 (green), -SCGB1A1 (red), and 
DAPI (blue). c, SARS-CoV-2 unspliced genomic RNA (left) and spliced 
subgenomic RNA (right) in apical-out distal lung organoids, 72h post-infection 
(h.p.i.), qPCR, n = 2 independent experiments. d, Anti-double-stranded RNA 
(dsRNA) IF, apical-out human distal lung organoids, mock vs. SARS-CoV-2, 48 
h.p.i. e, SARS-CoV-2 nucleocapsid protein (NP) IF, apical-out organoids, mock 
vs. 96 h.p.i. f, SARS-CoV-2-infected apical-out AT2 organoids, IF with the 
indicated antibodies, 96 h.p.i. g, IF colocalization of SARS-CoV-2 NP and 
SCGB1A1, apical-out distal lung basal organoids, 96 h.p.i. h, SARS-CoV-2 
infection cell type specificity in apical-out organoids, IF with the indicated 
antibodies. Inf = SARS-CoV-2 infected cell. In c-h, organoids were in suspension 
for 6-10 days (basal) and 3 days (AT2) prior to infection. All scale bars 20 µm 















Additional experimental details are in the Supplementary Methods.
Human tissue procurement and processing
All experiments performed in this work was approved by the Stan-
ford University School of Medicine Institutional Review Board and 
performed under protocol #28908. Standard informed consent for 
research was obtained in writing from all patients who contributed to 
this study prior to tissue procurement and all experiments followed 
relevant guidelines and regulations. Peripheral lung tissue within 1 cm 
of the visceral pleura was obtained from surgical discards from lobec-
tomies. For patients with suspected lung cancer, cases with clinical T4 
(American Joint Cancer Committee 6th edition) disease (e.g. features 
such as bronchial invasion or parenchymal satellite nodule/ metastases) 
were deferred. Normal tissue was harvested from the lung margin most 
anatomically distal to palpably well-defined lesions, or from uninvolved 
lobes in the case of pneumonectomies. Samples with tumors containing 
ill-defined margins were deferred. Tissue was either processed fresh or 
placed at 4 °C overnight and processed the following morning.
Mixed distal lung organoid culture
To isolate distal airway cells, lung parenchyma 1 cm from the visceral 
pleura was mechanically dissociated with Castro scissors, washed 
and incubated with 5 units/ml porcine elastase (Worthington), 100 
Kunitz Units/mL DNase I (Worthington), and Normocin (InvivoGen), 
and resuspended in two tissue volumes of lung organoid media, com-
prised of Advanced DMEM/F12 (Invitrogen) supplemented with 10 mM 
nicotinamide, n-acetyl cysteine, 1X B27 supplement minus vitamin A, 
recombinant human NOGGIN (100 ng/mL, R&D Systems), recombinant 
human EGF (50 ng/mL, R&D Systems), and TGF-beta inhibitor A83-01 
(100 nM, Tocris). This lung organoid medium was used for all experi-
ments except for Extended Data Fig. 4f. The tissue was then agitated for 
one hour at 37 °C and the resultant cell suspension was filtered through 
100 through 40 µm cell strainers and subjected to ammonium chloride 
red blood cell lysis. The cell pellet was then washed and resuspended 
in 10 volumes of reduced growth factor Basement Membrane Extract II 
(Trevigen). Cells in matrix were then plated in 24-well plates in 50 micro-
liter droplets, and warm media was added after the droplets solidified 
for ten minutes at room temperature Media was changed every 3-4 days 
and organoids were passaged every 3-4 weeks by dissociation with Try-
pLE. Passaging was based on ECM durability/integrity and estimated 
organoid confluency, judged by estimated organoid volume to volume 
of the ECM droplet. Distal lung organoids could be passaged for ~6 
months with basal organoids initially exhibiting 6-7 doublings every 
2 weeks. Alveolar organoids expanded more slowly with an initial rate 
of 3-4 doublings/2 weeks but predominated over basal organoids after 
several months. Based on initial cell division rates, the upper limits of 
basal and alveolar expansion were 219 (524,288 fold) and 216 (65,536 fold) 
respectively. To rule out contamination by malignant cells, long-term 
cultures were systematically evaluated for the presence of dysplasia or 
carcinoma by a board-certified pathologist. In addition, five long-term 
organoid cultures (2-6 months) underwent targeted Next Generation 
Sequencing to exclude pathogenic nucleotide variants (see below). 
Full details are provided in Supplementary Methods.
Tandem MACS stromal depletion and EPCAM purification of 
distal lung cells
Distal lung was dissociated as above, and all incubation steps were 
carried out on ice. 107 cells were incubated with Fc Block (Biolegend 
422301) and diluted 1:100 in FACS buffer (2 mM EDTA and 0.2% fetal calf 
serum in 1X PBS pH 7.4), for ten minutes followed by APC-conjugated 
anti-CD45 antibodies at 1 µg/mL in FACS buffer for 30 minutes, washed, 
and subjected to two rounds of depletion with magnetic beads accord-
ing to manufacturer’s protocol (Miltenyi: anti-human fibroblast 
130-050-601, anti-CD31 130-091-935, anti-APC 130-090-855, LS column
130-042-401). Unlabeled cells were then centrifuged at 300 x g and
labeled with a cocktail of 1 µg/mL of PerCP-Cy5.5 anti-EPCAM antibody 
and Zombie Aqua viability stain (Biolegend 423101) diluted 1:400 from 
stock concentration in FACS buffer.
Organoid Cryopreservation and Recovery
For cryopreservation and recovery, ECM droplets were dissociated by 
pipetting in 3 volumes of PBS + 5 mM EDTA and then incubated on ice for 
one hour. Cells were pelleted at 300 x g for 5 minutes and resuspended 
in freezing medium (fetal calf serum (Gibco), 10% v/v DMSO), placed 
into cryovials and then into Mr. Frosty™ (Thermo Fisher) containers 
and stored in a -80C freezer overnight, followed by transfer to liquid 
nitrogen vapor phase for long term storage. Organoids were recovered 
by quick thaw in a 37 °C water bath followed by washing in organoid 
media and plating in ECM with organoid media plus 10 µM ROCK inhibi-
tor Y-27632 (Tocris).
Screening exogenous growth factors in organoid culture
Distal airway cells were isolated and plated as above with the following 
exceptions: Advanced DMEM/F12 was used instead of organoid medium 
during elastase digestion of lung tissue, cells were serially diluted and 
filtered through a 40 micron cell strainer and counted with a hemocy-
tometer. 1000 viable epithelial cells (by Trypan blue exclusion, size, and 
morphology) per µl ECM were plated per 5 µl Matrigel droplet per well. 
Base media consisted of organoid media lacking A83-01, EGF, NOGGIN, 
WNT3A or RSPO1. EGF (final 50 ng/mL, R&D), NOGGIN (final 100 ng/
mL, R&D), WNT3A (final 100 ng/mL, R&D), RSPO1 (final 500 ng/mL, 
Peprotech) or the PORCUPINE inhibitor C59 (final 1 µM, Biogems) were 
added singly or in combination to base media. Images were obtained 
ten days after primary plating with an inverted light microscope at 5X 
magnification. Each condition was plated in quadruplicate and orga-
noid formation was quantified using the analyze particle (threshold = 
4902 pixels) plugin in ImageJ as previously described65.
Single Cell RNA-seq of unfractionated organoid cultures
Lung organoid cultures from separate individuals were dissociated 4 
weeks after primary plating and subjected to droplet based scRNA-seq 
with the 10x Genomics Single Cell 3’ platform with a 5 nucleotide UMI 
according to manufacturer’s protocol. Cell capture, library prepara-
tion, and sequencing were performed as previously described37. For 
scRNA-seq analysis in Fig. 1k, a modified Kruskal-Wallis Rank Sum Test 
was performed to determine significance of differential marker gene 
expression for AT2 (SFTPC), basal (KRT5), and club (SCGB1A1), with all 
p-values < 0.001. Principle Component Analysis, t distributed Stochas-
tic Neighborhood Embedding, unsupervised Graph based clustering, 
statistical testing, pseudotime trajectory for all scRNA-seq analyses 
are described in Supplementary Methods and Supplementary Data 1.
Single cell RNA-seq of purified AT2 organoid cultures
LysoTracker+ AT2 cells38 from unfractionated organoids were purified by 
FACS and cultured for two months with one passage. These were dissoci-
ated and subjected to droplet-based scRNA-seq with the 10x Genomics 
Chromium Single Cell 3’ platform v2 according to the manufacturer’s 
protocol. The library was sequenced using paired-end sequencing (26bp 
Read 1 and 98bp Read 2) with a single sample index (8bp) on an Illumina 
NextSeq 500. Data preprocessing and Principle Component Analysis 
were carried out with CellRanger v1.2. Subsequent analysis is described 
in Supplementary Methods and Supplementary Data 1.
Electron microscopy
Organoid cultures were fixed in ECM with 2.5% glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.4), dehydrated, embedded in epoxy resin and 
visualized with a JEOL (model JEM1400) transmission-electron micro-















Organoids were fixed with 2% paraformaldehyde at 4 °C overnight, 
paraffin embedded and sectioned (10-20 µm) as previously described37. 
Sections were deparaffinized and stained with H&E for histological 
analysis. Antibodies used for immunocytochemistry staining are listed 
in Supplementary Methods following standard staining protocols39 and 
images acquired on a Leica-SP8 confocal microscope.
RNA fluorescent in situ hybridization
RNA in situ hybridization was performed according to Nagendran 
et al.40 and probe sequences are provided in Supplementary Methods.
Whole-mount organoid confocal immunofluorescence 
microscopy
Intact, uninfected organoids were fixed in 2% paraformaldehyde in 
100 mM phosphate buffer (pH 7.4) (4% paraformaldehyde for infected 
organoids) for one hour at room temperature, washed with PBS with 
100mM glycine, permeabilized 0.5% Triton X-100 in PBS for 1 h, then 
incubated in staining buffer (4% BSA, 0.05% Tween-20 in PBS pH 7.4, 10% 
goat/donkey serum) for an additional hour, followed by incubation with 
primary antibody for 24 h at room temperature in staining buffer. Whole 
mounts were then washed with PBS-T and incubated with fluorescent 
secondary antibodies, phalloidin and DAPI, for four hours at room 
temperature in staining buffer. Following additional washes, whole 
mounts were submerged in mounting media (VECTASHIELD, Vector 
Laboratories) and mounted on chambered coverslips for imaging in 
four channels using Zeiss LSM 700 or 900 confocal microscopes. 3D 
rendering of confocal image stacks was performed using Volocity Image 
Analysis software (Quorum Technologies Inc., Guelph, Ontario). For 
Figure 5j, requiring 5 colors, cilia were distinguished by staining with 
two fluorescent secondary antibodies and merging the colocalized 
voxels into a pseudocolored channel using Volocity software. Lectin 
staining (FITC-Sambuca Nigrin, Vector Labs FL-1301; Biotin-Maackia 
Amurensis, Vector Labs FL-1301) was carried out according to manu-
facturer’s protocol after fixation of organoids with 0.1% paraformalde-
hyde in PBS for 1 hour at room temperature followed by blocking with 
Avidin/Biotin (Vector Labs SP-2001). Biotin-Maackia Amurensis lectin 
was labeled with streptavidin-PE conjugate (Thermo Fisher SA10041) 
and after washing lectin staining was imaged in a Keyence BZ-X700.
Next generation sequencing of organoid cultures
Ten organoid cultures were sequenced using a commercial targeted 
resequencing assay with end-to-end coverage of 131 cancer genes and 
companion software (TOMA COMPASS Tumor Mutational Profiling Sys-
tem, Foster City, CA) to determine the presence of oncogenic mutations 
in long-term organoid cultures. Libraries were sequenced on an Illumina 
NextSeq 500. Nonsynonymous variants are listed in Supplementary 
Table 6. Variant Call Files are provided in Supplementary Data 2.
Density sedimentation of basal cells
Organoid cultures within 2-3 weeks of primary plating were dissociated 
with 1 U/mL neutral protease (Worthington, Cat LS02100) and 100 KU 
of DNase I in lung organoid media. Basal organoids were then collected 
by gravity sedimentation and the supernatant was either aspirated or 
collected for downstream use. Basal organoids were then further frac-
tionated on a custom Ficoll-Paque gradient (4 vol Ficoll-Paque to 1 vol 
PBS) and centrifuged at 300 x g for 10 minutes at room temperature. 
Supernatant was aspirated and the organoid pellet resuspended in 
10 ml PBS in a 15 mL conical tube, collected by gravity sedimentation, 
and plated into ECM as described above.
FACS isolation and culture of AT2 cells
Organoids were dissociated with TrypLE followed by neutralization 
with 10% volume fetal calf serum, subjected to DNase at 100 kU/mL, 
washed with lung organoid media and then incubated with 100 cell 
pellet volumes of lung organoid media with 10 nM LysoTracker Red 
DND-99 (Thermo Fisher L7528) at 37 °C for 30 minutes. Cells were then 
washed and resuspended in FACS buffer as described above, incubated 
with Fc block, followed by incubation on ice with labeling cocktail con-
sisting of 1 µg/mL of PerCP-Cy5.5 anti-EPCAM antibody and Zombie 
Aqua viability stain (Biolegend 423101) diluted 1:400 from stock con-
centration in FACS buffer. EPCAMhi and LysoTrackerhi cells were sorted 
into lung organoid media + 10 µM Y-27632 (Tocris 1254) and cultured in 
ECM and lung organoid media with Y-27632 for 24 hours, followed by 
lung organoid media without Y-27632. Pure AT2 organoid growth was 
enhanced by addition of 1:1 vol:vol serum-containing L-cell conditioned 
media (L-WRN CM) containing WNT3A, R-SPONDIN3 and NOGGIN and 
supplemented with recombinant EGF41. Full gating strategy is provided 
in Supplementary Figure 1. All FACS antibodies were purchased from 
Biolegend. Qualitatively identical results could also be obtained with 
anti-HTII-280 (AT2 marker, Terrace Biotech) FACS purification in lieu 
of LysoTracker. AT2 organoid cells were transdifferentiated to AT1 
cells by TrypLE dissociation from ECM and seeding onto chambered 
glass coverslips followed by culturing with Advanced DMEM/F12 + 5% 
fetal calf serum42.
Color mixing studies with lentivirally transduced GFP and 
mCherry
FACS EPCAM+ stromal-depleted organoids at d14 were infected with 
lentivirus at an estimated MOI of 0.9 according to Van Lidth de Jeude 
et al.43 with third generation lentiviral vectors (PGK-GFP T2A Puro, SBI 
cat# CD550A-1; mCherry modified from pLentiCRISPRv1 (Addgene 
#49545) to incorporate an EF-1a-mCherry P2A Puro cassette, a gift 
from Paul Rack). 96 hours after infection, organoids were treated with 
puromycin at a concentration of 600 ng/mL for 48 hours to select for 
transduced cells. Two weeks after selection, GFP-expressing organoids 
or mCherry-expressing organoids were dissociated to single cells 
and mixed in a 1:1 ratio and scored as monochromatic or mixed after 
28 days of each passage. The same approach was employed for purified 
AT2 and basal cultures after respective purification strategies from an 
initial FACS EPCAM+ stromal depleted organoid starter culture.
Flow cytometry analysis of resident basal cells from adult 
human lung
Adult human lung tissue was procured and dissociated as above but 
cells were labeled with Zombie Aqua live:dead stain as above, washed 
with FACS buffer, and then fixed in 2% PFA in PBS overnight at 4 °C . 
Cells were then stained using the whole mount procedure as described 
above with the omission of PBS glycine washing. Fixed and permeabi-
lized cells were then incubated with 1:400 dilution of Alexa Fluor 647 
conjugated mouse anti-human cytokeratin 5 antibody (Abcam) for 
24 hours at 4 °C in permeabilization buffer. Cells were then washed 
with FACS buffer and labeled with PE conjugated mouse anti-human 
TNFRSF12A antibody (clone ITEM-4, Biolegend) for 30 minutes on ice, 
followed by washing and analysis on a BD Aria Fusion instrument. Full 
gating strategy and qPCR validation of ITEM-4 antibody is detailed in 
Supplementary Figure 1.
FACS isolation of TNFRSF12Ahi and TNFRSF12Aneg basal cells
Single cell suspensions from either fresh human distal lung or primary 
organoid culture at approximately 4 weeks of culture were dissoci-
ated as above, treated with Fc Block (BioLegend), and incubated in 
FACS buffer with Zombie Aqua 1:400, 1 µg/mL PerCP-Cy5.5 anti-human 
EpCAM (CD326), 1 ug/mL APC anti-human ITGA6 (CD49f), 2 ug/mL FITC 
anti-human ITGB4 (CD104), and 1 µg/mL PE anti-human TNFRSF12A 
(CD266). 30 minutes after labeling the cells were washed twice with 
FACS buffer and sorted for EPCAMhi, ITGA6/ITGB4hi, TNFRSF12Ahi 
and TNFRSF12Aneg. Full gating strategy is provided in Supplementary 














organoid medium and 10 µM ROCK inhibitor Y-27632. All FACS anti-
bodies were purchased from Biolegend.
Culture of TNFRSF12Ahi and TNFRSF12Aneg basal cells
Cells were seeded in ECM and submerged in lung organoid media with 
10 µM ROCK inhibitor Y-27632. Seeding density for cells FACS isolated 
from organoid culture was 1000 cells per well at a density of 100 cells/µl 
of ECM. Seeding for cells FACS isolated from fresh human distal lung was 
3000 cells per well at a density of 300 cells/µl of ECM. After 24 hours, 
the media was changed to remove ROCK inhibitor and additionally 
changed every 72 hours. Organoid formation was manually quantified 
14 days post plating by two independent observers.
H1N1 organoid influenza assay
Unfractionated cultures containing AT2, basal, and club cell types at 
2-3 weeks were infected in triplicate with PR8 strain of H1N1 modified to 
express GFP upon viral replication44 after 24 hours of pretreatment with 
antiviral compounds. ECM was dispersed by addition of 5 mM EDTA in 
PBS, followed by washing and inoculation with PR8-H1N1-GFP reporter 
virus at an estimated MOI of 1 in media containing either vehicle or 
antivirals. After 12 hours (one influenza infection cycle), intact organoid 
GFP expression was visualized by either fluorescence microscopy with 
a Keyence BZ-X700 automated microscope, or dissociated to single 
cell, fixed with 0.1% PFA in PBS followed by FACS quantitation of GFP+ 
cells (Gating Strategy is provided in Supplementary Figure 1). Antiviral 
dose response curves were generated using four-parameter nonlinear 
regression curve fitting with GraphPad Prism 7 (GraphPad Software, San 
Diego, CA). H1N1 tropism was assessed in a manner similar to above with 
the exception of Ficoll sedimented basal cell fraction versus non-basal 
fractions were dissociated to single cells, counted, and infected with an 
estimated MOI of 1 in organoid media for one hour at 37 °C, followed 
by washing and reseeding into ECM, cultured for 16 hours, followed by 
dissociation and FACS as above.
Suspension culture to generate apical-out polarity in lung 
organoids
Lung organoids grown embedded in 50 µl ECM droplets were trans-
ferred to suspension culture as described28 with modifications. Briefly, 
ECM-embedded organoids were dislodged gently by pipetting using 
sterile LoBind tips (Eppendorf 22493008) and placed in 15 ml LoBind 
conical tubes (Eppendorf 30122216) containing ice-cold 5 mM EDTA 
in PBS. 5 ml of EDTA solution was used per ECM-droplet (3 ECM drop-
lets/15 ml conical) rotating 1 h at 4 °C on a rotating platform. Organoids 
were centrifuged at 200 x g for 3 min at 4 °C and the supernatant was 
removed. The pellet was re-suspended in growth media in ultra-low 
attachment 6-well tissue culture plates (Corning Costar 3471). Sus-
pended organoids were incubated at 37 °C with 5% CO2 for different 
times (range 0-30 days) to characterize apical-out polarity, ciliogen-
esis, differentiation, and to prepare apical-out organoids for infection 
experiments with SARS-CoV-2.
SARS-CoV2 infection of human distal lung organoids
VeroE6 cells were obtained from ATCC and maintained in supplemented 
DMEM with 10% FBS. SARS-CoV-2 (USA-WA1/2020) was passaged in 
VeroE6 cells in DMEM with 2% FBS. Titers were determined by plaque 
assay on VeroE6 cells using Avicel (FMC Biopolymer) and crystal violet 
(Sigma), viral genome sequence was verified, and all infections were 
performed with passage 3 virus. Organoids were counted and passaged 
into suspension media for 6-8 days and then resuspended in virus media 
or an equal volume of mock media, at a MOI of 1 relative to total orga-
noid cells in the sample, and then incubated at 37 °C under 5% CO2 for 
2 hours. Organoids were then plated in suspension in lung organoid 
media (apical-out organoids). At the indicated timepoints, organoids 
were washed lung organoid media and PBS and either resuspended in 
TRIzol LS (Thermo Fisher), freshly-made 4% PFA in PBS, or 250 µl lung 
organoid media. Cells resuspended in lung organoid media were lysed 
by freezing at -80 °C. Culture supernatants were preserved in TRIzol 
LS or added directly to plaque assay monolayers. All SARS-CoV-2 work 
was performed in a class II biosafety cabinet under BSL3 conditions at 
Stanford University.
qPCR analysis of SARS-CoV-2 RNA
RNA from SARS-CoV-2-infected organoids was extracted by adding 750 µl 
TRIzol (Thermo Fisher Scientific), incubating at 55 °C for 5 min and then 
adding 150 µl chloroform. After mixing each sample by vortexing for 
7 s, the samples were incubated at 25 °C for 5 min and then centrifuged 
at 12,000 r.p.m. for 15 min at 4 °C. The aqueous layer was carefully 
removed from each sample, mixed with two volumes of 100% ethanol 
and purified using an RNA Clean & Concentrator-25 kit (Zymo Research) 
as per manufacturer instructions. All RNA samples were treated with 
DNase (Turbo DNA-free kit, Thermo Fisher Scientific). The Brilliant II 
SYBR Green QRT-PCR 1-Step Master Mix (VWR) was used to convert RNA 
to cDNA and amplify specific RNA regions on the CFX96 Touch real-time 
PCR detection system (Bio-Rad). RT reaction was performed for 30 min 
at 50 °C, 10 min at 95 °C, followed by two-step qPCR with 95 °C for 
10 seconds and 55 °C for 30 seconds, for a total of 40 cycles. Two 
primer sets were used, either to amplify non-spliced SARS-CoV-2 
genomic RNA (gRNA) spanning nucleotide positions 14221-14306, or 
spliced SARS-CoV-2 sgRNA30. Primer sequences are in Supplementary 
Table 7.
TNFRSF12A immunostaining of intact distal lung
Optimal staining of human distal lung tissue was achieved from speci-
mens fixed within 30 minutes of primary surgical resections in 4% para-
formaldehyde in PBS. Specimens were incubated in fixative overnight at 
4 °C, transferred to 30% sucrose, and embedded into OCT. 10 µm thick 
frozen sections were cut, subjected to citrate based antigen retrieval 
(Vector labs) at 70 °C for 30 minutes, followed by blocking for one 
hour with 10% goat serum in IF wash buffer as described above. Mouse 
anti-TNFRSF12A (clone ITEM-4, Biolegend) was utilized for Fig. 3a and 
polyclonal rabbit anti-TNFRSF12A (ThermoFisher PA5-20275) was used 
for Fig. 3b, f and Extended Data Fig. 845
Live-imaging and confocal microscopy of immobilized 
apical-out lung organoids
Live organoids were held between two coverslips in a viewing cham-
ber (Lab-Tek II two-chambered coverglass) and filmed using a Nikon 
TE2000E microscope using differential interference contrast (DIC) 
microscopy with a 63X objective. Samples were kept at 37 °C with 
5% CO2 during imaging. Digital videos were collected by a Hama-
matsu high-resolution ORCA-285 digital camera and rendered using 
OpenLab 5.5.2 software (Improvision). After recording, samples 
were fixed and stained without removal from the chambers and 
transferred to the confocal microscope for immunofluorescence 
microscopy.
Statistics and reproducibility
Unless stated otherwise, all data are representative of at least two inde-
pendent experiments with each independent experiment carried out 
using an organoid culture derived from a unique individual. Box plot 
bounds span first through third quartiles, horizontal lines represent 
median values, and whiskers represent data range minima or maxima 
or in the case of outliers, 1.5 times the interquartile range with outli-
ers represented by data points. t-tests were two-tailed and p values 
are denoted as * = < 0.05, ** = < 0.01, and *** = < 0.001. Full details are 
provided in Supplementary Methods.
Reporting summary
Further information on research design is available in the Nature 















scRNA-seq datasets have been deposited in Gene Expression Omnibus 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE106850) 
with the accession code GSE106850. Source data are provided with 
this paper.
Code availability
Scripts to perform analyses of scRNA-seq data are provided with 
this paper. Custom code is available on GitHub (https://github.com/
ameen-salahudeen/lung_organoid).
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Extended Data Fig. 1 | Optimization of human distal lung organoid culture. 
a, Schematic of culture initiation from human distal lung. b, Brightfield 
microscopy evaluation of required exogenous growth factors and automated 
organoid quantitation after day 10 of chemically defined organoid culture with 
specified recombinant growth factors, N=Noggin, E=EGF, W=WNT3A, 
R=RSPO1, n = 4 per condition, data are mean +/-SEM, *= p < 0.05, two-tailed 
student’s t-test, scale bar = 500 µm. c, Left, purification schema to isolate 
epithelial cells from distal human lung involving negative MACS bead 
depletion of CD45+ hematopoietic cells, endothelial cells and fibroblasts, 
followed by positive FACS selection for EPCAM+ epithelium. Bottom left, 
representative FACS demonstrating > 99.9% EPCAM+ purity (orange) upon 
re-analysis versus unstained controls (grey). Bottom right, proliferation of 
EPCAM+ cells purified from distal lung cultures after day 10 of organoid culture 
with specified growth factors, N=Noggin, E=EGF, W=WNT3A, R=RSPO1, n = 3 
per condition, data are mean +/- SEM, ** = p < 0.01, two-tailed student’s t-test.  
d, Time lapse transmission confocal images of solid and cystic organoids 
originating from single dissociated human distal lung cells, scale bar = 100 µm. 
e-g, Clonality mixing studies. e, Schema of mixing studies of lentivirus-
GFP- and lentivirus-mCherry-expressing cells to determine clonality. 
f, Representative live fluorescent imaging of resultant green and red organoids 
from (e), scale bar = 500 µm. g, Quantitation of red, green, or chimeric, distal 















Extended Data Fig. 2 | scRNA-seq of human distal lung organoids cultured 
from three individuals reveals reproducible basal, club, and AT2 
populations. a-c, unsupervised clustering of total cell populations 
demonstrates consistency in top differentially expressed genes corresponding 
to basal (KRT5/6), club (SCGB1A1), and AT2 (SFTPC) cells. The epithelial fraction 
from these cultures ranged from approximately 90-99% of all cells with the 
remainder being either fibroblasts (VIM+) or mononuclear cells (HLA-DR+, 
likely alveolar macrophages). d-f, t-SNE visualization and violin plots for marker 
genes corresponding to each population. Note, a unique population enriched 
for SPRR genes, which have been described as marker in squamous metaplasia, 
were exclusively found in the organoid culture of Lung 3, derived from an 













Extended Data Fig. 3 | Trajectory inference with SPADE and pseudotime.  
a, SPADE plot of pooled cells where each point represents cell states that are 
more related on the same or adjacent branches of a minimum spanning tree. 
Note: AT2 cells exist on a branch distal to basal and club cells, suggesting no 
lineage hierarchy between AT2, basal, and club cells. b, SPADE plots of pooled 
scRNA-seq samples after excluding AT2, VIM+ and HLA-DR+ cells support 
lineage relationships between basal (blue) and club (red) populations by club 
cell branches emanating from basal cells. c, SPADE plots of Basal 1, Basal 2, and 
club populations. d, Left, gene expression of SCGB1A1 shows higher expression 
in club versus basal cell lineages (left) as compared to KRT5 (middle). Right, 
median gene expression of TNFRSF12A, showing a high (orange outline) and a 
low (blue outline) within basal cell branches and inferring a potential lineage 
relationship. e, Monocle 3 pseudotime trajectory analysis of single-cell 
transcriptomes of Basal 1 connected to club cells depicted with UMAP  














Extended Data Fig. 4 | Human AT2 organoid characterization. a, Left, 
confocal images of a live AT2 organoid at 67 days of culture labeled with 
Hoescht nuclear stain and LysoTracker Red DND-99. Top right, isolation of 
purified AT2 organoids. Representative FACS plots showing LysoTracker Red 
AT2 purification from unfractionated organoid cultures. Bottom right, 
immunostaining of cytospin of LysoTracker-sorted AT2 cells show high purity 
(100/100 cells SPC+ SCGB1A1- KRT5); scale bar = 50 µm). b, Schema of FACS 
isolation of AT2 cells from human mixed distal lung organoids as 
EPCAM+LysoTracker+ AT2 cells followed by long-term clonogenic organoid 
culture. c, Representative image of clonal mixing studies from 
stroma-depleted, EPCAM+LysoTracker+, lentivirally-marked AT2 cells 
demonstrating presence of completely mCherry+ or GFP+ but not chimeric 
organoids carried out as in Extended Data Fig. 1e-g, passage 1 after lentiviral 
infection, scale bar = 200 µm. d, Quantitation of red, green, or chimeric, AT2 
organoid cultures as in (c) from two individuals (1, 2) after initial and serial 
passaging (P1=passage 1). e, AT2 organoid proliferation with differing 
combinations of recombinant niche factors and PORCUPINE inhibitor C59 (1 
mM), NOGGIN (N), EGF (E), WNT3A (W), R-SPONDIN1 (R). n = 3 per condition, 
data are mean +/- SEM, * = p < 0.05, *** = p < 0.001, two-tailed student’s t-test.  
f, Brightfield microscopy comparing pure AT2 organoid growth enhancement 
in chemically defined lung organoid media (EN) versus serum-containing L-cell 
conditioned media containing WNT3A, NOGGIN, and R-SPONDIN3 (L-WRN CM) 
supplemented with recombinant EGF, 1 independent experiment. Scale bar = 
200 µm. g, Transmission electron microscopy image of representative AT2 
organoid at 28 days of culture. Note apical microvilli (black arrows) and 














Extended Data Fig. 5 | a-c, Basal organoids in mixed culture progressively 
form internal lumens, which is not associated with apoptosis. a, KRT5 IF, 
day 26 culture, scale bar = 200 µm. b. Lumen quantitation, d12 versus d26 
culture, single determination. c, Absence of apoptosis in d26 basal cell 
organoid internal lumen, cleaved caspase IF, from Fig. 2b, scale bar = 20 µm. 
d-e, Isolation of purified basal cell organoids via differential sedimentation in 
Ficoll. d, Schema and enrichment to > 90% KRT5+ cells as measured by 
intracellular KRT5 FACS of sedimented basal organoid cells; scale bar = 100 µm. 
e, Serial time lapse microscopy of sedimented basal organoids reveals 
spontaneous cavitation within two weeks post passage or within four weeks of 
culture initiation; scale bar = 25 µm. f-g, Clonal mixing studies from 
stroma-depleted, Ficoll-purified and lentivirally-marked basal organoid cells 
demonstrating fully mCherry+ or GFP+ but not chimeric organoids as in 
Extended Data Fig. 1f, passage 1 after lentiviral infection, scale bar = 200 µm.  
f, Representative clonal mixing image study. g, Quantitation. h, Growth factor 
evaluation for basal organoids after d14 sedimentation, enzymatic dissociation 
and clonogenic culture. Growth was not affected by the PORCUPINE inhibitor 














Extended Data Fig. 6 | scRNA-seq identifies an active basal cell 
subpopulation across three individual patient organoid cultures. a, High 
resolution clustering analysis identifies a reproducible active basal cell 
subpopulation with significantly higher expression of mRNAs for TNFRSF12A, 
the NOTCH pathway marker HES1, and the proliferation marker MKI67. 
Modified Kruskal-Wallis Rank Sum Test two tail p-values: TNFRSF12A 4.15 x 10-8; 
HES1 2.4 x 10-10; MKI67 3.4 x 10-3. b, Fine resolution clustering of KRT5+ 
populations identifies two Basal 1 sub-clusters, Basal 1.1 and 1.2. c, Gene 
Ontology PANTHER overrepresentation of differentially expressed genes 
enriched in Basal 1.2 versus 1.1 show the majority of Basal 1.2 processes involve 
cell cycle (asterisks). Complete analysis is provided in Supplementary Table 3. 
d, Violin plot of scRNA-seq analysis for Fig. 2f-h depicting KRT5 mRNA 
expression among triply EPCAM+ITGA6+ITGB4+ mRNA-expressing single cells 
(purple, i.e. tandem mRNA expression of all three genes) versus the remainder 
of cells (gray), p < 0.001 two tailed Kruskal-Wallis Rank Sum Test. e, t-SNE 
visualization of TNFRSF12A and ITGA6 expression from the left panel among 
cells with EPCAM+ITGA6+ITGB4+ gene expression and subdivision by high (top 
quartile, orange), medium (pink) and low (bottom quartile, navy blue) mRNA 
expression. f, Proliferation-associated gene expression is progressively 
enriched for scRNA-seq cell fractions of in EPCAM+ITGA6+ITGB4+ cells that are 
stratified for low, medium, or high expression of TNFRSF12A mRNA as in (e). 
Data in f represent cell population fractions from a single experiment.  














Extended Data Fig. 7 | Evaluation of Basal 1 lineage relationship to  
Basal 2 and the influence of NOTCH signaling on Basal 1 renewal and 
differentiation. a, Isolation of Basal 1 and Basal 2 via differential sedimentation 
of KRT5+ cells followed by FACS sorting of EPCAM+ITGA6+ITGB4+TNFRSF12A+ 
(Basal 1) versus EPCAM-ITGA6-ITGB4-TNFRSF12A- (Basal 2). b, Intracellular 
FACS measurement of KRT5 protein expression in Basal 1 and 2 fractions from 
(a). c, Representative brightfield of day 14 organoid cultures from (a-b).  
d, Quantitation of 3 independent experiments from (a-c), boxplot represents 
first quartile, median, third quartile, and whiskers represent minimum and 
maximum. *** p < 0.001, two tailed student’s t-test. e, qPCR measurement of 
two differentially upregulated Basal 2 genes from the three scRNA-seq 
biological replicates (Extended Data Fig. 6, SPRR1B, TMSB4X) after prolonged 
culture of FACS isolated Basal 1 cells. Data are relative mean +/- SEM of cultures 
from three independent experiments, ** = p < 0.01, two tailed student’s t-test.  
f, RNA FISH demonstrating TMSB4X and SPRR1B cellular transcripts within 
organoids originating from Basal 1 cells (arrows), scale bar = 25 µm. g, KRT5 
immunostaining and SFTPC and SCGB1A1 RNA FISH of FACS isolated 
TNFRSF12Ahi Basal 1 cells under vehicle, NOTCH agonism (JAG1 peptide), or 
NOTCH antagonism with the Delta-like ligand mutant 4 (DLL4E12; E12) or the 
gamma secretase inhibitor DBZ; scale bar = 50 µm. h, Fluorescent quantitation 
of resazurin dye reduction to estimate relative cellular proliferation in (g),  
data are normalized to vehicle (V) and represent mean +/- SEM from five 
independent experiments, * p < 0.05, two tailed student’s t-test. i, Quantitation 
of SCGB1A1 and SFTPC gene expression by RNA FISH in the context of NOTCH 
agonism or antagonism from three independent experiments, ** p < 0.01,  
*** p < 0.001, two tailed student’s t-test. SFTPC mRNA upregulation was not 












Extended Data Fig. 8 | TNFRSF12A marks a subset of distal airway basal cells 
in vivo. a-b, Immunostaining of KRT5 and TNFRSF12A in human distal airways 
from two individuals, scale bar = 100 µm. c, Immunostaining of KRT5, 
TNFRSF12A, and p63 in human distal airway, scale bar = 100 µm. d, FACS 
analysis from freshly fixed human distal lung with anti-KRT5 (intracellular) and 
monoclonal anti-TNFRSF12A (cell surface) (top), or sequential FACS isolation 
from freshly dissociated human distal lung of EPCAM+ITGA6+ITGB4+ cells 
followed by fractionation into TNFRSF12Ahi or TNFRSF12Aneg subsets (bottom), 














Extended Data Fig. 9 | Influenza infection modeling in mixed distal lung 
organoid cultures. a-b, Distal lung organoid modeling of H1N1 influenza 
infection. a, Merged transmission and GFP confocal images of purified basal 
(left) and purified AT2 organoids (right) 12 hours after infection with PR8-GFP 
H1N1 influenza virus, quantified by FACS for % GFP+ cells. Bar plot represents 
the mean percentage of infected cells from three technical replicates, p = 0.57, 
Chi-square test. Scale bars = 50 µm. b, Viral genome quantitation over time of 
mixed distal lung organoid culture supernatants subjected to initial infection 
of wild-type H1N1 at an estimated multiplicity of infection (MOI) of 0.01, 
qRT-PCR, data represent the mean of three independent experiments +/- SEM. 
c-d, Lectin staining with M. amurensis (a2-3) and S. nigra (a2-6) lectins or no 
lectin negative controls to characterize sialic acid residues which serve as 
surface molecules for influenza virus host cell entry. AT2 organoids (c) and 
basal organoids (d). Scale bar = 25 µm. e, Dose response curves for two different 
classes of antiviral drugs on influenza infectivity and replication. The 
nucleoside analog FdC demonstrated dose dependent activity with IC50 of 340 
nM as compared to neuraminidase inhibitor zanamivir, only impairs viral 
shedding, but not infectivity and replication. n = 3 per condition, data 
represents mean +/- SEM. f, Fluorescence micrograph of multiwell screening of 
selected various antiviral agents after H1N1 PR8-GFP organoid infection in 48 














Extended Data Fig. 10 | Apical-out polarization and multi-lineage 
differentiation of distal lung organoids upon suspension culture.  
a-b, Formation of apical-out lung organoids. a, scRNA-seq plots of ACE2 and 
TMPRSS2 gene expression in non-everted mixed distal lung organoids as in 
Fig. 1a–h. b, Diagram of ECM removal and suspension culture leading to 
apical-out polarity of lung organoids. c, Representative confocal microscopy 
showing reorganization of microfilaments (phalloidin) and acetylated 
microtubules (AcTUB) upon ECM removal. Scale bar = 10 µm. d-f, Eversion and 
accelerated ciliary differentiation of apical-out basal organoids. d, Confocal 
3D sections (top panels) and surface reconstructions (bottom panels) of 
apical-out lung organoids at different days after ECM removal. At day 0 (d0) 
microfilament (green, phalloidin) and microtubule (red, acetylated tubulin) 
organization is not polarized while junctional strands (ZO-1, white) are 
polarized. By day 2 in suspension (d2) ZO-1 (white) forms junctional rings in the 
apical periphery of each cell facing the external side of the organoids and the 
actin cytoskeleton forms microvilli (green) facing outward (apical-out 
polarity). Also at d2 some cells initiate microtubule polarization. By day 5 (d5) 
many more cells have motile cilia facing outwards. Mature motile cilia can be 
observed for several weeks, example at day 14 (d14). e, 3D confocal 
reconstruction of an organoid embedded in ECM consisting mostly of basal 
stem cells (KRT5+, white). f, As apical-out polarity is established and ciliagenesis 
begins, KRT5+ basal cells are found underneath the polarized epithelium.  
g, SCGB1A1+ Club cells with apical-out polarity can are present on the exterior 
everted surface. In all panels nuclei are stained blue with DAPI, and actin 
microfilament organization visualized with phalloidin (green). Scale bars = 10 
µm. h-j, Prolonged suspension culture of AT2 organoids (day 10 post-eversion) 
induces apical-out polarization and AT1 differentiation. h, Optical sections 
through alveolar-derived organoids after 10 days in suspension culture show 
decreased abundance of AT2 cells while individual cuboidal cells begin to 
express the AT1 marker HTI-56 (red), a transmembrane protein specific to the 
apical membrane of alveolar type 1 pneumocytes (AT1). Scale bars = 10 µm.  
i-j, Side views of alveolar organoids after 10 days of suspension culture 
reveal thin AT1 cells with phalloidin-reactive apical junctional complexes 
facing outwards (apical-out) (i) and expression of HTI-56 on the apical 
membrane ( j). Scale bars = 10 µm. k, Representative confocal microscopy 
immunofluorescence of apical-out human basal organoid after 10 days in 
suspension expressing SARS-CoV-2 receptor ACE2 (green), cilia (AcTUB, red) 
and DAPI (blue). Scale bar = 20 µm.
